Identification of novel human leukocyte antigen‐A*11:01‐restricted cytotoxic T‐lymphocyte epitopes derived from osteosarcoma antigen papillomavirus binding factor-Reference-Cited by-同舟云学术

Identification of novel human leukocyte antigen‐A*11:01‐restricted cytotoxic T‐lymphocyte epitopes derived from osteosarcoma antigen papillomavirus binding factor

Published:2019-03-12 Issue:4 Volume:110 Page:1156-1168
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Li Dongliang¹,Toji Shingo¹,Watanabe Kazue¹,Torigoe Toshihiko²,Tsukahara Tomohide²^ORCID

Affiliation:

1. Ina Laboratory, Medical & Biological Laboratories Co., Ltd Ina Japan

2. Department of PathologySapporo Medical University School of Medicine Sapporo Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13973

Reference35 articles.

1. Common Musculoskeletal Tumors of Childhood and Adolescence

2. Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

3. Effect of Timing of Pulmonary Metastases Identification on Prognosis of Patients With Osteosarcoma: The Japanese Musculoskeletal Oncology Group Study

4. Current advances in T-cell-based cancer immunotherapy

5. Identification of Human Autologous Cytotoxic T-Lymphocyte-Defined Osteosarcoma Gene That Encodes a Transcriptional Regulator, Papillomavirus Binding Factor

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies;Frontiers in Cell and Developmental Biology;2024-06-10

2. Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies;Frontiers in Endocrinology;2023-07-11

3. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment;Bone Research;2023-02-27

4. Novel Immunotherapies for Osteosarcoma;Frontiers in Oncology;2022-04-01

5. The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy;Human Vaccines & Immunotherapeutics;2021-05-14